Low symptomatic load in Crohn's disease with surgery and medicine as complementary treatments

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 423-429

  Andersson, P ^b   Olaison, G ^a   Bodemar, G ^b   Almer, S ^b   Arvidsson, M ^b   Dabrosin Soderholm J ^b   Nystrom P O ^b   Smedh, K ^b   Strom M ^b   Sjodahl R ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Crohn's disease; Drug therapy; Surgery; Treatment outcome

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; CYANOCOBALAMIN; FOLIC ACID; LOPERAMIDE; MESALAZINE; OPIATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROHN DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; RESIDENTIAL CARE; SYMPTOMATOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; COST OF ILLNESS; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME;

EID: 7144254453     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171062     Document Type: Article

References (38)

1. Kirsner JB. The local and systemic complications of inflammatory bowel disease. JAMA 1979;242:1177-83.
2. Tytgat GNJ, Mulder CJJ, Brummelkamp WH. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy 1988;20:260-2.
3. Rutgeers P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomoses after curative surgery. Gut 1984;25:665-72.
4. Olaison G, Smedh K, Sjödahl R. Natural course of Crohn's disease after ileocolic resection - early endoscopic ileal ulcers preceding symptoms. Gut 1992;33:331-3.
5. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990;99:956-62.
6. 2 activity. Scand J Gastroenterol 1992;27:691-4.
7. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984;86: 249-66.
8. Bello C, Goldstein F, Thornton JJ. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease. Am J Gastrenterol 1991;86:460-6.
9. Löfberg R, Rutgeerts P, Malchow H, Lamers C, Danielsson Å, Olaison G, et al. Budesonide prolongs time to relapse in ileal and ileocecal Crohn's disease. Gut 1996;39:82-6.
10. Thomson ABR, International Mezasalasine Study Group. Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. Aliment Pharmacol Ther 1990;4:55-64.
11. Prantera C, Francesco P, Brunetti G, Cottone M, Miglioli M. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. Gastroenterology 1992;103:363-8.
12. Gendre JP, Mary JY, Florent C, Modigliani R, Colombel JF, Soule JC, et al. Oral mesalamine as maintenance treatment in Crohn's disease: a multicenter placebo controlled study. Gastroenterology 1993;104:435-9.
13. Caprilli R, Andreoli A, Capurso L, Corrao G, Dalbasio G, Gioieno A, et al. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of of postoperative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994;8:35.
14. Messori A, Brignola C, Trallor G, Rampazzo R, Bardazzi G, Belloli C, et al. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a metaanalysis. Am J Gastroenterol 1994;89:6928.
15. Brignola C. Cottone M, Pera A, Ardizzone S, Scribano ML, De Franchis R, et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology 1995;108:345-9.
16. McLeod RS, Wolff BG, Steinhart AH, Carryer PW, O'Rourke K, Andrews DF, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
17. Present DH, Korelitz BI, Wish N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. N Engl J Med 1980;302:981-7.
18. Ewe K, Press A, Singe C, Stufler M, Uebershaer B, Hommel G, et al. Azathioprine combined with prednisolon or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993;105:367-72.
19. Bouhnik Y, Leman M, Mary JY, Scemama G. Tai R, Matuchansky C, et al. Long term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996;1:215-9.
20. Candy S, Wright JP, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995;37:664-8.
21. Lee ECG, Papaionnou N. Minimal surgery for chronic obstruction in patients with extensive or universal Crohn's disease. Ann Roy Coll Surg 1982;64:229-33.
22. Lee ECG. Aim of surgical treatment in Crohn's disease. Gut 1984;25:217-22.
23. Alexander-Williams J, Haynes IG. Conservative operations for Crohn's disease of the small bowel. World J Surg 1985;9:945-51.
24. Shorb PE. Surgical therapy for Crohn's disease. Gastroenterol Clin 1989;18:111-28.
25. Smedh K, Olaison G, Nyström PO, Sjödahl R. Intraoperative enteroscopy in Crohn's disease. Br J Surg 1993;80:897-900.
26. Smedh K, Olaison G, Sjödahl R. Endoscopic and exterior bowel changes and histopathology in Crohn's disease. Br J Surg 1995; 82:191-4.
27. Best WR, Becktel JM. The Crohn's disease activity index as a clinical instrument. In: Pena A, Weterman IT, Booth CC, Strober W, editors. Recent advances in Crohn's disease. The Hague: Martinus Nijhoff; 1981. p. 7-12.
28. Armitage P, Berry G. General contingency tables. In: Statistical methods in medical research. 3rd ed. Oxford: Blackwell Science Ltd; 1994. p. 232-3.
29. Lindberg E, Järnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 1991;26:495-500.
30. Hellers G. Crohn's disease in Stockholm County 1955-1974: a study of epidemiology results of surgical treatment and long-term prognosis. Acta Chir Scand 1979;Suppl 490:1-83.
31. Munkholm P, Langholz E, Haagen Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87. A sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
32. Lindgren A, Wallerstedt S, Olsson R. Prevalence of Crohn's disease and simultaneous occurence of extraintestinal complications and cancer. An epidemiologic study in adults. Scand J Gastroenterol 1996;31:74-8.
33. Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979;77:847-69.
34. Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
35. Heiman T, Greenstein A, Mecanic L, Aufses A. Early complications following surgical treatment for Crohn's disease. Ann Surg 1984;201:494-8.
36. Stokes M, Hill G. One hundred operations for Crohn's disease. Aust N Z J Surg 1990;60:677-82.
37. Simi M, Leardi S, Minervini S, Pietroletti R, Schietroma M, Speranza V. Early complications after surgery for Crohn's disease. Neth J Surg 1990;42-4:105-8.
38. Post S, Betzler M, von Ditfurth B, Shurman G, Kuppers P, Herfarth C. Risks of intestinal anastomosis in Crohn's disease. Ann Surg 1991;213:37-42.